University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 13 of 27
PES Family Support and Follow-Up Program
NCT03655119
Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation
NCT03774797
Physical Activity, Cognition, Motor Skills, and Well-beings
NCT05033197
Iron and Insulin Resistance in Overweight and Obese Humans
NCT03348020
Augmenting Exposure Therapy With Self-Distancing
NCT03549455
Colchicine in Postoperative Fontan Patients
NCT03575572
Evaluation of Web-based Transition Education to Enhance Transition Readiness
NCT03303248
Obesity Prevention in Head Start
NCT03672227
Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
NCT03503513
Phase 1A Study of the Safety of KSP/QRH Dimer
NCT03643068
De-implementation of Low Value Castration for Men With Prostate Cancer
NCT03579680
E-health Resilience Program For Chronic Spine Pain
NCT03667040
Facial Mucosal Level Determinants for Single Immediately Placed Implants Evaluated by Novel Ultrasonography
NCT03558282
Fluids Affecting Bladder Urgency and Lower Urinary Symptoms
NCT03625492
Project VOICE: Vascular Outcomes Improvement Through Collection of PatiEnt Reported Data
NCT03554564
Effect of Exercise and Surgical Weight Loss on Polyneuropathy
NCT03617185
Improving Student Mental Health: Adaptive School-based Implementation of CBT
NCT03541317
Diagnostic Device for the Assessment of Pulpal Blood Flow
NCT03578549
Caffeine and Neurologic Recovery Following Surgery and General Anesthesia
NCT03577730
Comparison of Envelope Coronally Advanced Flap and Modified Tunnel Technique in Soft Tissue Dehiscence Around Implants
NCT03498911
Evaluation of Metoprolol Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis
NCT03612180
We Prevent: A Dyadic Approach to HIV Prevention and Care Among Young Male Couples
NCT03551938
Non-invasive Brain Stimulation in Adults Who Stutter
NCT03437512
Peer Mentorship to Reduce Suicide Attempts Among High-Risk Adults
NCT03373916
Stroke Ready - Optimizing Acute Stroke Care
NCT03645590
Kiwifruit, Prunes, & Fiber for Abdominal and Bowel Symptoms in US Patients With Chronic Constipation
NCT03569527
Saferteens in Primary Care
NCT03410238
Wheelchair Cushion Comparison Study: SAFETY
NCT03430375
Feasibility Study of a Modified Yoga Program for Elders
NCT04343625
Skin Barrier Dysfunction and the Role of Skin Barrier Restoration
NCT03728569
Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus
NCT03589443
Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant
NCT03458897
Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention
NCT03368456
SafERteens M-Coach
NCT03344666
Studying the Treatment Effect of Pirfenidone in Chronic Lung Allograft Dysfunction (STOP-CLAD)
NCT03473340
Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial
NCT03493204
Mechanistic Studies of Teriflunomide in RRMS
NCT03464448
Rehabilitation for Arm Coordination and Hand Movement in Systemic Sclerosis
NCT03482219
Increased Liver Stiffness: A Study of Acoustic Radiation Force Impulse (ARFI) Elastography
NCT03382119
Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes
NCT03244722
2018 Intern Health Study Micro-randomized Trial
NCT03972293
Testing of a New Therapeutic Vibration Device to Reduce Neuromuscular Weakness in Hospitalized Patients
NCT03479008
Operative Versus Non-Operative Treatment for Atraumatic Rotator Cuff Tears
NCT03295994
Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis
NCT02315898
Functional Resistance Training to Improve Knee Function After ACL Reconstruction
NCT03282565
Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm
NCT03462641
Evaluation of a Community Health Worker (CHW)-Led Program
NCT03924713
Improving Accuracy of Landmarks for Neuraxial Blocks in Pregnancy: The Sacral Anatomical Interspace Landmark (SAIL) Technique
NCT03433612
A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing
NCT03219528
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence
NCT03396874
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.